IL2 and chronic graft versus host disease: In support of this notion, IL-2 treatment was found to be effective against chronic GVHD in humans and although more than 50% of patients were concomitantly treated with a calcineurin inhibitor in this clinical study, many of them still exhibited an elevation in Treg numbers and showed disease improvement [27].